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Background: Reduced heart rate recovery (HRR) in coronary artery disease (CAD) is predictive of
increased cardiovascular mortality and is related to reduced parasympathetic tonus.
Objective: To investigate HRR and heart rate variability (HRV) measured at steady state condition
and the relationship between these two parameters in CAD.
Materials and Methods: In our study, we enrolled 33 (28 males, mean age 52.4 ± 9.6 years)
patients with CAD who did not have heart failure, atrial fibrillation, pacemaker, and any disease state
that could affect the autonomic functions and 38 age-matched healthy subjects (21 males, mean age
48.3 ± 7.8 years). All the patients underwent submaximal treadmill exercise testing (Bruce protocol).
HRR was calculated by subtracting the heart rate values at the 1st, 2nd, and 3rd minutes of the recovery
phase from the peak heart rate (HRR1, HRR2, HRR3). Before exercise testing, short-term steady state
HRV analyses of all subjects were obtained with the time- and frequency-domain methods and were
correlated to HRR. For frequency-domain analysis, low-frequency HRV (LF, 0.004–0.15 Hz), high-
frequency HRV (HF, 0.15–0.5 Hz), and LF/HF ratio were measured for 5 minutes in the morning. For
time-domain analysis, standard deviation of the normal-to-normal NN intervals (SDNN), square root
of the mean squared differences of successive N-N intervals (RMSSD), and proportion derived by
dividing the number of interval differences of successive N-N intervals greater than 50 ms by the total
number of N-N intervals (pNN50) were obtained. Only HRR3 was used for the correlation analysis.
Results: In CAD groups, the HF, an indicator of parasympathetic activation, was significantly re-
duced, whereas the LF and LF/HF values, which are indicators of sympathetic activity, were increased
(P = 0.0001 for each parameter). The time-domain parameters SDNN, RMSSD, and pNN50 were
significantly reduced in the patient group (P = 0.0001, P = 0.009, and P = 0.0001, respectively).
Similar to the HRV parameters, the HRR1, HRR2, and HRR3 values were significantly reduced in
the patient group (P = 0.0001 for each parameter). We observed a significant negative correlation
between HRR3 and LF (r = −0.67, P = 0.0001) and between HRR3 and LF/HF (r = −0.62, P <
0.0001), while there was a significant positive correlation between HRR3 and HF, SDNN, RMSSD,
and pNN50 (r = 0.69, P = 0.0001; r = 0.41, P = 0.0001; r = 0.31, P = 0.008; and r = 0.44, P =
0.0001).
Conclusions: HRR and HRV are significantly reduced in CAD. The reduction in HRR is parallel
to the changes in HRV parameters. HRR, which can be measured easily in the recovery phase of
exercise testing, can be used to detect the depression of parasympathetic tonus and to evaluate the
basal autonomic balance in this patient group. A.N.E. 2006;11(2):154–162
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Despite impressive advances during the past three
decades, ischemic heart disease remains a major
health problem in Western societies. Impairment of
autonomic cardiovascular regulation has been ob-
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served in many disease states including ischemic
coronary artery disease (CAD). The relevance of
this impairment for clinical cardiology was real-
ized in the late 1980s, when the results of impaired
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autonomic function were found to predict mor-
tality among patients with CAD who have expe-
rienced acute myocardial infarction.1 Heart rate
variability (HRV), a measure of sympathetic and
parasympathetic influences on the heart, is reduced
in the presence of autonomic dysfunction. The
presence of subclinical or clinical autonomic dys-
function is associated with increased mortality.1–3
Another measure of parasympathetic function is
heart rate recovery (HRR); an easily obtained mea-
sure derived from routinely graded exercise test-
ing. HRV analysis is very useful in evaluation of
sympathovagal modulation of cardiovascular func-
tions when compared with the classical methods,
and it has a wide range of usage area.4,5 Dur-
ing exercise, an increase of sympathetic activity
and a decrease of vagal discharge lead to an in-
crease of heart rate, stroke volume, and myocardial
contractility to satisfy energy demands of working
muscles. Exercise cardioacceleration results from
release of parasympathetic inhibition at low ex-
ercise intensities and from both parasympathetic
inhibition and sympathetic activation at moderate
intensities.6 Autonomic contribution to cardiode-
celeration after exercise (HRR) is less well under-
stood. Inactive recovery from dynamic exercise is
associated with cessation of primary exercise stim-
ulus from the brain (cerebral cortex—central com-
mand), which is responsible for the initial rapid
drop of heart rate.2 Slower changes in the stimuli
to metaboreceptors and baroreceptors accompany-
ing clearance of metabolites and delayed elimina-
tion of body heat and catecholamines are thought
to be other factors contributing to HRR after phys-
ical activity. Nevertheless, parasympathetic acti-
vation is considered to be the main mechanism
underlying exponential cardiodeceleration after ex-
ercise.6–9 The rate of decrease in heart beat fre-
quency and the length of time to recovery af-
ter moderate-to-heavy exercise is commonly used
as indicators of cardiovascular fitness.5 Recently,
a delayed decrease in heart rate during the 1st
minute after exercise has been suggested to be a
powerful and independent predictor of all-cause
mortality.8,10–12
Although the relationship between HRR and
parasympathetic activity during the recovery phase
after exercise is very well-known, its relation with
the autonomic system functions during resting pe-
riod is not understood exactly. For this reason, in
our study, we aimed to examine the changes in
HRR and basal HRV measurements in ischemic
CAD, as well as the relationship between HRR and
basal HRV parameters.
MATERIALS AND METHODS
Thirty-three patients with CAD (28 males, mean
age 52.4 ± 9.6 years), who were admitted to our
clinic with stable angina pectoris between January
2003 and June 2004, were enrolled in this study.
All patients underwent submaximal exercise (tread-
mill) testing and their coronary angiograms were
obtained. Thirty-eight healthy subjects (21 males,
mean age 48.3 ± 7.8 years) with atypical angina
pectoris, negative exercise testing, and normal
coronary angiograms were enrolled in the control
group. Routine physical examination, 12-lead elec-
trocardiography, chest x-rays, routine biochemi-
cal analyses, and transthoracic echocardiography
were obtained from all subjects. Patients with docu-
mented heart failure or left ventricular systolic dys-
function (left ventricular ejection fraction (LVEF) ≤
40%), valvular heart disease, pulmonary disease,
atrial fibrillation, history of acute myocardial in-
farction, any disease state that could affect auto-
nomic functions, implanted pacemakers, and those
using beta-blockers were excluded from this study.
The local ethics committee approved the protocol
and all participants gave informed consent.
HRV Measurement
A standard ambulatory Holter recording sys-
tem (Biomedical System Century 2000/3000 Holter
monitoring system, version 1.32, St. Louis, Mis-
souri) was used. A 3-channel recorder was used to
record the electrocardiographic traces. All record-
ings were analyzed by Biomedical Systems Cen-
tury 2000/3000 HRV package system. The Holter
recordings were obtained for an hour between 9.30
and 12.30 a.m. in a dark room, the patients had
fasted for 12 hours, and were kept in recumbent
position throughout the recordings. The subjects
were asked to remain awake, but the depth and rate
of breathing were not controlled. Only the beats
that had normal morphological characteristics were
used for analysis. Intervals between ectopic beats,
between normal and ectopic beats, and between
the beats that could not be measured properly be-
cause of the artifacts were excluded from the anal-
ysis. HRV was assessed by two ways: time- and
frequency-domain analyses.
156  A.N.E.  April 2006  Vol. 11, No. 2  Evrengul, et al.  Coronary Artery Disease
Time-domain HRV indexes: standard deviation
of the normal-to-normal QRS intervals (SDNN),
square root of the mean squared differences of suc-
cessive N-N intervals (RMSSD), and proportion de-
rived by dividing the number of interval differences
of successive N-N intervals greater than 50 ms by
the total number of N-N intervals (pNN50). SDNN
and RMSSD were calculated after detrending the
heart rate series.
The mean heart rate, the standard deviation
of all R-R intervals (SDNN), the standard devia-
tion of mean R-R intervals in 5-minute recordings
(SDANN), the square root of the sum of squares of
the successive R-R intervals between which there
was a difference of greater than 50 ms divided by
the number of all R-R intervals (pNN50) were used
for the time-domain analysis. The Fourier trans-
form method was used for the spectral measure-
ments and the heart rate spectrum between 0.003
and 0.40 Hz was defined as total energy (ms2). This
power was divided into two components: low fre-
quency (LF, 0.004–0.15 Hz) and high frequency
(HF, 0.15–0.5 Hz). It was assumed that HF is a
marker of parasympathetic activity, LF is a mea-
sure of sympathetic activity, LF is a measure of
sympathetic activity, and LF/HF ratio is an indi-
cator of sympathovagal balance.13,14
Exercise Testing Protocol
Subjects underwent a submaximal exercise test
according to the standard Bruce protocol.15 Ex-
ercise was terminated when subjects achieved
their target HR, defined as 85% of the age and
sex-predicted maximal HR.16 After reaching peak
exercise, patients immediately got off the tread-
mill and rested in a supine position. The 12-
lead electrocardiogram, HR, and blood pressure
were monitored during exercise and for 4 min-
utes of recovery. Exercise testing was termi-
nated prematurely for the following reasons: symp-
toms such as limiting chest or leg discomfort,
or dyspnea; a decrease in systolic pressure be-
tween consecutive stages; exercise systolic pres-
sure ≥ 250 mmHg; development of significant
electrocardiographic abnormalities, including ≥
2 mm ST-segment depression; or complex ventric-
ular ectopy. An ischemic ST-segment response was
defined as a ≥ 1 mm horizontal or down sloping
ST-segment depression (measured 80 ms after the J-
point) during exercise or recovery when compared
with the electrocardiogram at rest.
HRR was calculated by subtracting the heart rate
values at the 1st, 2nd, and 3rd minutes of the recov-
ery phase from the peak heart rate (HRR1, HRR2,
HRR3). Only HRR3 was used for the correlation
analysis.
The coronary angiographies of all the subjects
enrolled in this study were performed and ana-
lyzed by experienced cardiologists who were not
informed about the patients’ data. The lesions re-
sulting in narrowing of the artery lumen > 70%
were evaluated as severe coronary artery stenosis.
Severe stenosis of more than one major epicardial
coronary artery or > 50% lesion in main coronary
artery were accepted as a multivessel disease.
STATISTICS
All statistical analyses were performed by com-
puter pack software SPSS 11.5 (Statistical Package
for Social Sciences, SPSS Inc., Chicago, IL, U.S.A.).
Results are given as mean ± standard deviation.
Student t-test was used for comparison of groups.
Chi-square and Student unpaired t-tests were used
for analysis of nonparametric data and Fisher test
was used for proportional data. The relationship
between HRR and HRV parameters was evaluated
by Pearson correlation analysis. A P value of <0.05
was considered statistically significant.
RESULTS
Thirty-three patients with positive exercise test
and established CAD in their coronary angiogra-
phies and 38 subjects with normal coronary arter-
ies and negative exercise test were enrolled in the
study. As summarized in Table 1, there was no sta-
tistically significant difference between the patient
and control groups according to cardiac risk factors,
LVEF, and mean age. Male gender and nitrate us-
age were significantly higher in the patient group
with CAD as compared to the control group (Table
1). There was no significant difference between the
systolic and diastolic blood pressure of the groups,
measured at the beginning of the exercise test.
However, the systolic blood pressure increased sig-
nificantly with exercise in the patient group (P
= 0.0001). Exercise time was found to be signifi-
cantly longer in the control group, although their
basal heart rates were higher (P = 0.0001, Table 2).
The HRR values measured during the recovery
phase (HRR1, HRR2, HRR3) were significantly
lower in the patient group (P = 0.0001, for each
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Table 1. Clinical Characteristics of the Patient and Control Groups
CAD (+) CAD (−) P Value
Number 33 38
Age (years, mean ± SD) 52.4 ± 9.6 48.3 ± 7.8 ns
Sex (males/females) 28/5 21/17 0.007
Cardiac risk factors, n (%)
History of familial CAD 10 (30.3%) 13 (34.2%) ns
Hypertension 15 (45.5%) 18 (47.3%) ns
Diabetes mellitus 4 (12.2%) 3 (7.8%) ns
Smoking 19 (57.5%) 25 (65.7%) ns
Hyperlipidemia 6 (17.1%) 8 (21%) ns
Obesity (BMI > 30 kg/m2) 5 (15.1%) 6 (15.7%) ns
Drug usage
Aspirin 16 (48.8%) 10 (26.3%) ns
Beta-blocker 0 (0%) 0 (0%) ns
Ca antagonist 0 (0%) 0 (0%) ns
Antiarrhythmics 0 (0%) 0 (0%) ns
ACEI 13 (39.3%) 15 (39.4%) ns
Nitrates 16 (48.8%) 12 (31.5%) 0.004
Single vessel disease, n(%) 12 (36.3%) 0 (0%)
Multiple vessel disease, n (%) 21 (63.7%) 0 (0%)
LV ejection fraction (%, mean ± SD) 52.9 ± 5.4 54.4 ± 8.1 ns
BMI = body mass index; CAD = coronary artery disease; LV = left ventricle; ACEI = angiotensin
converting enzyme inhibitors; SD = standard deviation; ns = nonsignificant.
parameter, Table 2, Fig. 1). There was no significant
difference between the groups according to their
mean heart rate values measured during the Holter
recordings. However, SDNN, which is a rough mea-
sure of HRV (P = 0.0001) and RMSDD (P = 0.009)
and pNN50 (P = 0.0001) values, which are indica-
tors of parasympathetic activity, were significantly
higher in the control group (Fig. 1, Table 3). Simi-
larly, HF, an indicator of parasympathetic activity,
was higher (P = 0.0001), whereas LF and LF/HF val-
ues, indicators of sympathetic activity, were signifi-
cantly lower (P = 0.0001, for each parameter) in the
control group. The correlation between HRR and
Table 2. Exercise Characteristics and Heart Rate Recovery Indexes in the Patient and Control Groups
(mean ± SD)
CAD (+) Control Group P Value
Basal heart rate 82.4 ± 12.5 100.4 ± 4.4 0.0001
Basal systolic blood pressure 130.9 ± 15.5 125.4 ± 10.5 0.08
Basal diastolic blood pressure 85.4 ± 6.9 84.2 ± 7.3 0.7
Peak systolic arterial pressure 180.0 ± 11.1 155.4 ± 14.4 0.0001
Peak diastolic arterial pressure 83.3 ± 8.8 74.0 ± 10.0 0.0001
Exercise duration 6.9 ±2.7 10.6 ± 2.1 0.001
Peak heart rate 145.0 ± 9.4 154.3 ± 9.7 0.003
HRR1 23.6 ± 4.8 31.9 ± 9.4 0.0001
HRR2 40.4 ± 10.0 54.4 ± 13.7 0.0001
HRR3 49.8 ± 9.8 70.4 ± 16.6 0.0001
HRR = heart rate recovery index; CAD = coronary artery disease.
HRV parameters is summarized in Table 4 and Fig.
2. HRR3 was negatively correlated to LF and LF/HF,
which are indicators of sympathetic activity. How-
ever, HRR3 was significantly and positively corre-
lated to HF, RMSSD, pNN50, and SDNN.
DISCUSSION
HRV analysis is a convenient and safe method
used for evaluation of the autonomic nervous sys-
tem functions in various cardiovascular and non-
cardiovascular disorders.5 HRV analysis is made
by two methods: time- and frequency-domain















































Figure 1. Heart rate recovery and heart rate variability parameters in patients
and controls.
analyses. In the time-domain analysis, SDNN, the
standard deviation of R-R intervals, represents a
general measurement of autonomic nervous system
balance, whereas the pNN50, which is calculated
by division of the number of adjacent R-R inter-
vals differing by more than 50 ms by the number
of total R-R intervals, predominantly reflects the
parasympathetic activity. The spectral analysis of
R-R intervals in the frequency-domain analysis is
made in two ways: high frequency (HF, the spectral
component between 0.16 and 0.5 Hz)) and low fre-
quency (LF, the spectral component between 0.04
and 0.15 Hz). HF is modulated predominantly by
the parasympathetic nervous system, whereas LF
is under the influence of both parasympathetic and
sympathetic nervous systems. The HF/LF ratio is a
marker of the sympathovagal balance.5,13
Abnormal autonomic function is known to pre-
dispose to arrhythmias in various clinical and ex-
perimental conditions. Sympathovagal imbalance
(either increased sympathetic activity or reduced
vagal activity) has been shown to be a strong and
independent predictor of mortality in patients with
myocardial infarction, heart failure, or diabetic
neuropathy.17–20 Conversely, predominance of va-
gal activity has protective and antifibrillatory ef-
fects.17 HRV has been shown to be altered among
patients with stable CAD and reduced even before
the development of symptoms. In 1987, Airaksinen
et al. were the first to report the reduced vagal ac-
tivity among patients with CAD.21 The HF compo-
nent of the heart rate is impaired in uncomplicated
CAD, particularly during sleep, and the reduction
in HRV is correlated with the angiographic severity
of the CAD.22,23
The patient population of our study consists of
patients without a history of AMI and with rela-
tively preserved LVEFs. The ratio of diabetes mel-
litus, which is known to affect autonomic func-
tions, is very low in both the patient and the control
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Table 3. Time- and Frequency-Domain HRV Parameters in the Patient and the Control Groups
CAD (+) Group Control Group P Value
Heart rate (beats/min) 72.7 70.5 0.14
SDNN (ms) 60.9 ± 24.7 90.4 ± 35.4 0.0001
SDANN (ms) 37.8 ± 26.4 47.7 ± 28.5 0.13
RMSSD (ms) 28.5 ± 25.5 47.8 ± 35.0 0.009
PNN50 (%) 5.4 ± 6.0 17.3 ± 15.1 0.0001
LF 65.7 ± 6.5 51.7 ± 16.9 0.0001
HF 34.1 ± 6.4 48.8 ± 16.7 0.0001
LF/HF 2.0 ± 0.7 1.2 ± 0.7 0.0001
HRV = heart rate variability; CAD = coronary artery disease; SDNN = standard deviation of the normal-to-normal N-N intervals;
SDANN = standard deviation of mean R-R intervals in 5-minute recordings; RMSSD = square root of the mean squared
differences of successive N-N intervals; pNN50 = proportion derived by dividing the number of interval differences of successive
N-N intervals greater than 50 ms by the total number of N-N intervals; LF = low frequency; HF = high frequency.
groups (Table 1). Our findings show that the spec-
tral component of HF is significantly reduced in un-
complicated CAD, and thus support the results of
previous studies. The reduction of HF spectral band
points to the dominance of LF control mechanism
in CAD. Fractal scaling properties of R-R intervals
have also shown to be altered among patients with
uncomplicated CAD.24 In our study, we observed
significant reductions in all the time-domain pa-
rameters except SDANN in the CAD group, and
these findings were concordant with the changes
in the frequency-domain parameters. The spectral
and time-domain HRV parameters were obtained
from short recordings in our study, during which all
patients were kept supine to provide stable condi-
tions. Similar to our findings, previous studies have
pointed out that frequency-domain analysis ob-
tained from short recordings are more useful in the
prediction of mortality and that time-domain anal-
ysis should be reserved for longer recording.25,26
Thus, the insignificance of the changes in SDANN
and the inconsistency of these changes with the pa-
rameters in frequency-domain analysis reported in
our study were not evaluated as contradictions.
Table 4. Correlation Analysis Between HRV
Parameters and HRR3
Correlation Coefficient P Value
SDNN (ms) 0.41 0.0001
SDANN 0.15 0.15
RMSSD (ms) 0.31 0.008




Although it has been shown that time- and
frequency-domain HRV parameters deteriorate in
ischemic heart disease, the exact mechanism of
these changes is not known. The clinical signif-
icance of postexercise HRR and its specificity as
an indicator of parasympathetic activity in the re-
covery phase has been noted by many investiga-
tors.27–29 Cole et al. have identified reduced HRR
as a strong and independent predictor of mortality,
while Imai et al. have found increased HRR in ath-
letes, but decreased HRR in heart failure.30,31 HRR
index is also a strong indicator of risk in asymp-
tomatic and symptomatic CAD, and it is indepen-
dent from the severity of CAD, Duke treadmill
score, and LVEF.32,33 In our study, HRR, like HRV,
was reduced significantly in the patient population,
similar to the findings of previous studies. CAD was
considered responsible for this reduction, because
the risk factors, clinical properties, and left ventric-
ular functions were similar in both the patient and
the control groups.
In healthy persons, the parasympathetic system
is dominant at rest; exercise is associated with
parasympathetic withdrawal and, as the intensity
of exercise is increased, with sympathetic activ-
ity.6 The autonomic changes associated with ces-
sation of exercise are not yet fully understood.
Savin et al. have observed significantly reduced
HRR values in individuals whose parasympathetic
systems were blocked with atropine after exercise
and suggested that parasympathetic reactivation,
not sympathetic withdrawal, was responsible for
the reduced heart rates in the recovery phase.34
Crouse et al., on the other hand, have found that
sympathetic blockade has very little influence on
HRR.35 These findings support that the parasympa-
thetic system is responsible for the reduced heart













































Figure 2. Correlation analysis between HRR3 and frequency-domain HRV param-
eters.
rates during the early stages of the recovery phase.
Similar results have been found in studies on the
relationship between the HRV and the HRR; how-
ever, there are few studies that investigate the rela-
tionship between HRR and HRV at rest, with con-
flicting results.27–29 Javorka et al., in their study
where they studied autonomic functions with the
HRV and complexity methods, have reported that
reduced postexercise HRR is not related to pre-
exercise HRV, but is strongly and significantly cor-
related with the HRV in the early recovery phase.29
Ohuchi et al., on the other hand, have found that
HRR was correlated with the HRV parameters mea-
sured at rest and during early recovery, in their
study on children using the baroreflex sensitiv-
ity and spectral HRV analysis methods.28 Pierpont
et al. have found no relationship between HRR and
the HRV parameters indicating parasympathetic
activity measured after maximal exercise, but ob-
served a significant correlation between these two
parameters measured after submaximal exercise.27
Although the results of the studies suggest a signif-
icant correlation between HRV and HRR in the re-
covery phase, there are conflicting results about the
HRV and HRR relationship at rest. The reasons for
these differences could be the differences between
patient populations, the relatively small number
of cases, and the methods used for HRV analysis.
The purpose of our study was to establish the re-
lationship between HRR and the HRV parameters
at rest; thus the patient population and the HRV
calculation method were chosen accordingly and
the postexercise HRV parameters were not sought
for. In our study, we found that HRR and HRV
were significantly reduced in uncomplicated CAD
and that HRR was significantly and positively cor-
related with the basal HRV parameters indicating
parasympathetic activity, and was significantly and
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negatively correlated with the basal HRV parame-
ters indicating sympathetic activity. Our findings
are similar to the results of Ohiki et al., although
we used different case selection criteria and differ-
ent methods of HRV analysis.28
The number of our patient population is lim-
ited because of the abundance of enrollment cri-
teria we used. Although our patient population
is homogeneous, it represents a very small per-
centage of patients with CAD; thus, its adaptabil-
ity to clinical usage is relatively limited. HRR is
closely related to the intensity of exercise, body
temperature, and cardiovascular conditioning.36,37
Another limitation of our study is in not having
evaluated the VO2 cardiovascular conditions of our
patients. However, Imai et al. have shown that
HRR measured 30 seconds after exercise indicated
parasympathetic activity independently of the in-
tensity of exercise and cardiovascular condition.31
In our study, HRR was measured 60, 120, and
180 seconds after exercise; for this reason, the ef-
fects of the exercise intensity and condition on HRR
can relatively be excluded. HRV parameters (espe-
cially HF) are influenced by respiratory rate and
depth, and it is usually recommended to control
the respiratory rate during recording.38 We did not
control the rate of breathing to avoid hypo- or hy-
perventilation that could result in metabolic and
blood gas changes.
CONCLUSIONS
In uncomplicated CAD, HRR and HRV param-
eters indicative of parasympathetic activity mea-
sured in basal conditions are significantly de-
pressed, but the HRV parameters indicating sym-
pathetic activity are augmented. HRR, which is
accepted as an indicator of the parasympathetic ac-
tivity just after cessation of exercise, is also pos-
itively correlated with the basal parasympathetic
activity. HRR, which can be measured easily in the
recovery phase of exercise testing, can be used for
evaluation of basal autonomic functions in patients
with CAD. However, this issue requires further
studies, conducted in larger patient populations.
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